Medlab Clinical $6.600
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 3:59am | ||||
MEDLAB CLINICAL LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
Medlab AGM Presentation
MDC released this announcement to the ASX on 30 September 2022, 10:46. The announcement is not marked as price sensitive, and is 23 page(s) in length and 15.65MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Medlab AGM Presentation | 30 September 2022, 10:46 |
| Medlab Progresses Nasdaq Dual Listing | 28 September 2022, 11:08 |
| Medlab Received 2022 R&D Claim | 26 September 2022, 10:57 |
| NanaBis and NanoCBD Clinical Development Update | 16 September 2022, 10:29 |
If you were already registered, log in here.
If you were already registered, log in here.